ICI Innovation of the Year 2022 Winner

Acorai, founded by a seasoned team of innovators, has created a first-of-its[1]kind non-invasive Intracardiac Pressure Monitor

▪ It matters because it is the only way to safely, accurately and cost[1]efficiently manage heart failure patients to improve quality of care

▪ Heart Failure affects more than 60 million people and costs >€300Bn globally

▪ Hospitals will buy our clinically validated solution without the need for

reimbursement as it reduces readmissions, complications and length of stay

▪ Acorai targets an initial global market size exceeding €9bn

▪ Six patent families protect Acorai’s SAVE sensor technology system

Skip to content

Manage Consent

We use cookies for essential operations, improving your experience, anonymous analytics, and personalized ads. You can allow all categories or fine-tune each one. Learn more: Privacy Policy